MedPath

Screening for colorectal cancer in the Netherlands;a study comparing attendance and feasibility of two different forms of faecal occult blood testing and sigmoidoscopy.

Recruiting
Conditions
1. Colorectal cancer
<br />2. screening
<br />3. attendance.
Registration Number
NL-OMON25308
Lead Sponsor
Initiator: Erasmus MC, University Medical Center RotterdamDepartment of Gastroenterology and hepatology
Brief Summary

Manuscript in progress.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
15000
Inclusion Criteria

1. 50-75 year old;

2. Ability to provide informed consent.

Exclusion Criteria

1. Inability or refusal to provide informed consent;

2. History of colorectal cancer, adenomas, inflammatory bowel disease*;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Attendance for CRC screening with guaiac based FOBT (Haemoccult II), immunochemical FOBT (OC-Hemodia Latex) and sigmoidoscopy.
Secondary Outcome Measures
NameTimeMethod
1. The diagnostic yield of FOBT screening and sigmoidoscopy based screening in the Netherlands;<br /><br>2. The feasibility and required capacity for primary sigmoidoscopy CRC screening in our country;<br /><br>3. The feasibility and required colonoscopy capacity needed for further evaluation of participants with a positive screening test in relation to the initial screening method used;<br /><br>4. Side effects of screening;<br /><br>5. Participants experiences; the acceptability, satisfaction and burden of screening (FOBT or sigmoidoscopy);<br /><br>6. Identification of optimal choices for implementation of a CRC screening program (process evaluation);<br /><br>7. Comparison of the cost-effectiveness ratio of the two forms of FOBT and sigmoidoscopy in CRC screening.
© Copyright 2025. All Rights Reserved by MedPath